| Literature DB >> 30319395 |
Lin Zhu1, Hao Shu1, Duan Liu1, Qihao Guo2, Zan Wang1, Zhijun Zhang1.
Abstract
The presence of both apolipoprotein E (APOE) ε4 allele and amnestic mild cognitive impairment (aMCI) are considered to be risk factors for Alzheimer's disease (AD). Numerous neuroimaging studies have suggested that the modulation of APOE ε4 affects intrinsic functional brain networks, both in healthy populations and in AD patients. However, it remains largely unclear whether and how ε4 allele modulates the brain's functional network architecture in subjects with aMCI. Using resting-state functional magnetic resonance imaging (fMRI) and graph-theory approaches-functional connectivity strength (FCS), we investigate the topological organization of the whole-brain functional network in 28 aMCI ε4 carriers and 38 aMCI ε3ε3 carriers. In the present study, we first observe that ε4-related FCS increases in the right hippocampus/parahippocampal gyrus (HIP/PHG). Subsequent seed-based resting-state functional connectivity (RSFC) analysis revealed that, compared with the ε3ε3 carriers, the ε4 carriers had lower or higher RSFCs between the right HIP/PHG seed and the bilateral medial prefrontal cortex (MPFC) or the occipital cortex, respectively. Further correlation analyses have revealed that the FCS values in the right HIP/PHG and lower HIP/PHG-RSFCs with the bilateral MPFC were significantly correlated with the impairment of episodic memory and executive function in the aMCI ε4 carriers. Importantly, the logistic regression analysis showed that the HIP/PHG-RSFC with the bilateral MPFC predicted aMCI-conversion to AD. These findings suggest that the APOE ε4 allele may modulate the large-scale brain network in aMCI subjects, facilitating our understanding of how the entire assembly of the brain network reorganizes in response to APOE variants in aMCI. Further longitudinal studies need to be conducted, in order to examine whether these network measures could serve as primary predictors of conversion from aMCI ε4 carriers to AD.Entities:
Keywords: Alzheimer’s disease (AD); amnestic mild cognitive impairment (aMCI); apolipoprotein E (APOE) ε4; functional connectivity; resting-state fMRI
Year: 2018 PMID: 30319395 PMCID: PMC6170627 DOI: 10.3389/fnagi.2018.00289
Source DB: PubMed Journal: Front Aging Neurosci ISSN: 1663-4365 Impact factor: 5.750
Demographic and neuropsychological data for all subjects.
| aMCI | Cohen’s | |||
|---|---|---|---|---|
| APOE ε3ε3 ( | APOE ε4+ ( | |||
| 17 (44.74%) | 13 (46.43%) | 0.891a | − | |
| 69.68 ± 7.17 | 71.5 ± 6.81 | 0.303b | − | |
| 7–18 years | 8–19.5 years | 0.869b | − | |
| MMSE | 26.08 ± 2.65 | 25.71 ± 3.10 | 0.963c | 0.13 |
| MDRS-2 total | 130.82 ± 6.92 | 129.50 ± 6.86 | 0.746c | 0.19 |
| Episodic memory | 0.13 ± 0.82 | −0.18 ± 0.87 | 0.259c | 0.37 |
| AVLT-20 min DR | 0.11 ± 1.03 | −0.14 ± 0.96 | 0.545c | 0.25 |
| LMT-20 min DR | 0.09 ± 0.98 | −0.12 ± 1.04 | 0.540c | 0.21 |
| CFT-20 min DR | 0.21 ± 1.01 | −0.28 ± 0.93 | 0.101c | 0.51 |
| Visuospatial function | 0.10 ± 0.80 | −0.13 ± 0.51 | 0.338c | 0.34 |
| CDT | 0.09 ± 1.02 | −0.12 ± 0.98 | 0.685c | 0.21 |
| CFT | 0.11 ± 1.31 | −0.14 ± 0.08 | 0.382c | 0.25 |
| Information processing speed | 0.02 ± 0.79 | −0.02 ± 0.82 | 0.638c | 0.05 |
| DSST | 0.04 ± 0.97 | −0.05 ± 1.06 | 0.810c | 0.09 |
| TMT-A | 0.04 ± 0.95 | −0.05 ± 1.07 | 0.926c | 0.09 |
| Stroop A | 0.01 ± 1.08 | −0.02 ± 0.90 | 0.613c | 0.03 |
| Stroop B | −0.02 ± 1.09 | 0.03 ± 0.88 | 0.556c | −0.05 |
| Executive function | 0.02 ± 0.55 | −0.03 ± 0.68 | 0.747c | 0.08 |
| VFT-objects | 0.02 ± 0.99 | −0.02 ± 1.03 | 0.870c | 0.04 |
| VFT-animals | 0.06 ± 0.92 | −0.08 ± 1.11 | 0.930c | 0.14 |
| DST-backward | −0.05 ± 0.97 | 0.06 ± 1.06 | 0.549c | −0.11 |
| TMT-B | 0.10 ± 0.97 | −0.13 ± 1.04 | 0.745c | 0.23 |
| Stroop C | −0.12 ± 1.04 | 0.17 ± 0.93 | 0.096c | −0.30 |
| Similarity | 0.13 ± 0.94 | −0.18 ± 1.06 | 0.331c | 0.32 |
Data are presented as mean ± standard deviation. The level of each cognitive domain and performance of each neuropsychological test are expressed as Z scores. aMCI, amnestic mild cognitive impairment; APOE, apolipoprotein E; MMSE, Mini-Mental State Exam; MDRS-2, Mattis dementia rating scale-2. AVLT, auditory verbal learning test; LMT, logical memory test; CFT, Rey-Osterrieth complex figure test; CDT, clock drawing test; CFT, Rey-Osterrieth complex figure test; DSST, digital symbol substitution test; TMT-A, trail making test-A; Stroop, Stroop color test; VFT, verbal fluency test; DST, digit span test; TMT-B, trail making test-B; Similarity, semantic similarity test. .
Figure 1Difference of FCS map between APOE ε3ε3 carriers and APOE ε4+ carriers. Compared with the APOE ε3ε3 carriers, the APOE ε4+ carriers showed significantly increased FCS values in the right hippocampus/parahippocampus. APOE, apolipoprotein E; HIP, hippocampus; PHG, parahippocampal gyrus; FCS, functional connectivity strength; **P < 0.01.
Figure 2Relationship between cognitive performances and regional FCS values in the aMCI patients carrying APOE ε4. The scatter plots show correlations between cognitive performance (e.g., episodic memory and executive function) and regional FCS values in the right hippocampus/para-hippocampal gyrus in the aMCI ε4 carriers. FCS, functional connectivity strength; aMCI, amnestic mild cognitive impairment; APOE, apolipoprotein E; MMSE, Mini-Mental State Exam.
Figure 3Seed-based RSFC maps. For the seed region, the RSFC patterns were largely similar across the APOE ε3ε3 and APOE ε4 groups. The color bar represents the strength of positive RSFC. APOE, apolipoprotein E; RSFC, resting-state functional connectivity.
Figure 4(A) APOE ε4-related alterations in the HIP/PHG-RSFC. Red: APOE ε4+ >APOE ε3ε3 (left middle occipital gyrus, right lingual gyrus and inferior occipital gyrus). Blue: APOE ε4+
Regions showing altered functional connectivity for APOE ε4 carriers and APOE ε3ε3 carriers using the right HIP/PHG seed (x = 30 mm, y = −36 mm, z = −6 mm).
| Brain regions | MNI coordinates (mm) | Clusters sizes (voxels) | ||
|---|---|---|---|---|
| Bilateral MPFC | 24 | 27 | −18 | 178 |
| Left middle occipital gyrus | −24 | −87 | 6 | 112 |
| Right lingual gyrus/inferior occipital gyrus | 33 | −90 | −6 | 83 |
APOE ε4-related alterations in the RSFC between the right HIP/PHG and bilateral MPFC, left middle occipital gyrus and right lingual gyrus/inferior occipital gyrus were observed, with significant lower values in bilateral MPFC and increased values in the left middle occipital gyrus and right lingual gyrus/inferior occipital gyrus in the APOE ε4 carriers compared to the APOE ε3ε3 carriers. APOE, apolipoprotein E; MPFC, medial prefrontal cortex; HIP, hippocampus; PHG, parahippocampal gyrus; RSFC, resting-state functional connectivity.
Correlations between regional FCS values and cognitive scores in aMCI.
| r, APOE ε3ε3 carriers ( | r, APOE ε4+carriers ( | Fisher’s | Cohen’s | |
|---|---|---|---|---|
| −0.221 | 0.90 (0.1833) | 0.2364 | ||
| −0.045 | −0.366 | 1.29 (0.0979) | 0.3388 | |
| −0.039 | −0.338 | 1.19 (0.1161) | 0.3128 | |
| −0.054 | 1.95 (0.0257) |
Multiple linear regression analyses were conducted to calculate the correlations between the regional FCS values and cognitive performance in the APOE ε3ε3 and APOE ε4 carriers, after controlling for age, gender and education. To statistically compute the differences in magnitudes of the correlations between the regional FCS values and cognitive performance in the APOE ε3ε3 and APOE ε4 carriers, correlation coefficients obtained above were further converted into z values by using Fisher’s r-to-z transform. A Z statistic was then used to compare these transformed z values to determine the significances of the between-group differences in correlations, and Cohen’s q was used to quantify the magnitude of difference between correlations; according to |Cohen’s q| < 0.20 is considered a small effect, 0.30 a moderate effect, and 0.50 a large effect. aMCI, amnestic mild cognitive impairment; APOE, apolipoprotein E; FCS, functional connectivity strength *.
Correlations between the HIP/PHG-RSFC with the bilateral MPFC and the cognitive performance in aMCI.
| r, APOE ε3ε3 carriers ( | r,APOE ε4+ carriers ( | Fisher’s | Cohen’s | |
|---|---|---|---|---|
| 0.253 | −0.8634 (0.1940) | −0.2261 | ||
| 0.036 | 0.163 | −0.4905 (0.3119) | −0.1285 | |
| 0.148 | 0.189 | −1.1612 (0.4360) | −0.0422 | |
| 0.194 | −1.2568 (0.1044) | −0.3291 |
Multiple linear regression analyses were conducted to calculate the correlations between the HIP/PHG-RSFC with the bilateral MPFC and cognitive performance in the APOE ε3ε3 and APOE ε4 carriers, after controlling for age, gender and education. aMCI, amnestic mild cognitive impairment; APOE, apolipoprotein E; HIP, hippocampus; RSFC, resting-state functional connectivity; MPFC, medial prefrontal cortex; PHG, parahippocampal gyrus *P < 0.05 **P < 0.01. Values in bold means that compared with HC group, these values make significant correlation with HIP/PHG-RSFC in aMCI patients.